Safety
sepsis, pneumonia, TEAEs, seizures
PNEUMONIA, RESPIRATORY FAILURE, ADVERSE EVENT, HYPOGLYCEMIA, SEPSIS
A total of 34 (97.1%) subjects experienced treatment-emergent AEs (TEAEs). Serious AEs (SAEs) were reported in seven (20.0%) subjects including infectious pneumonia, sepsis, hypoglycemia, seizures, and respiratory failure. No severe TEAEs or SAEs were related to the use of the study drug (Table Adverse events of the safety setData are presented as 